全文获取类型
收费全文 | 4939篇 |
免费 | 107篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 64篇 |
妇产科学 | 56篇 |
基础医学 | 750篇 |
口腔科学 | 128篇 |
临床医学 | 308篇 |
内科学 | 1133篇 |
皮肤病学 | 66篇 |
神经病学 | 210篇 |
特种医学 | 100篇 |
外科学 | 813篇 |
综合类 | 14篇 |
预防医学 | 120篇 |
眼科学 | 45篇 |
药学 | 590篇 |
中国医学 | 25篇 |
肿瘤学 | 564篇 |
出版年
2023年 | 24篇 |
2022年 | 46篇 |
2021年 | 110篇 |
2020年 | 40篇 |
2019年 | 74篇 |
2018年 | 71篇 |
2017年 | 43篇 |
2016年 | 76篇 |
2015年 | 68篇 |
2014年 | 140篇 |
2013年 | 132篇 |
2012年 | 224篇 |
2011年 | 272篇 |
2010年 | 148篇 |
2009年 | 149篇 |
2008年 | 248篇 |
2007年 | 285篇 |
2006年 | 347篇 |
2005年 | 327篇 |
2004年 | 328篇 |
2003年 | 298篇 |
2002年 | 337篇 |
2001年 | 126篇 |
2000年 | 132篇 |
1999年 | 134篇 |
1998年 | 91篇 |
1997年 | 76篇 |
1996年 | 69篇 |
1995年 | 53篇 |
1994年 | 36篇 |
1993年 | 54篇 |
1992年 | 61篇 |
1991年 | 57篇 |
1990年 | 50篇 |
1989年 | 56篇 |
1988年 | 44篇 |
1987年 | 40篇 |
1986年 | 39篇 |
1985年 | 24篇 |
1984年 | 24篇 |
1983年 | 15篇 |
1981年 | 9篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 6篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1971年 | 7篇 |
1967年 | 5篇 |
排序方式: 共有5066条查询结果,搜索用时 15 毫秒
81.
Tomoka Tabata Yuki Kuramoto Tomohito Ohtani Hiroshi Miyawaki Yohei Miyashita Fusako Sera Hidetaka Kioka Shuichiro Higo Yoshihiro Asano Shungo Hikoso Yasushi Sakata 《Internal medicine (Tokyo, Japan)》2022,61(13):1987
Phospholamban p.Arg14del is reported to cause hereditary cardiomyopathy with malignant ventricular tachycardia (VT) and advanced heart failure. However, the clinical courses of Japanese cardiomyopathy patients with phospholamban p.Arg14del remain uncharacterized. We identified five patients with this variant. All patients were diagnosed with dilated cardiomyopathy (DCM), developed end-stage heart failure and experienced VT requiring implantable cardioverter defibrillator discharge. Four patients survived after implantation of a left ventricular assist device (LVAD), while one patient who refused LVAD implantation died of heart failure. Based on the severe course of the disease, we propose genetic screening for phospholamban p.Arg14del in DCM patients. 相似文献
82.
Shingo Machida Reo Kato Kaishi Hasegawa Takahiro Gotoh Ken-ichi Katsumata Atsuo Yasumori 《Materials》2022,15(15)
Photoreduction of Cu2+ ions to Cu metal by titanium(IV) oxide (TiO2) was conducted in the presence of a silica–surfactant hybrid under sulfuric acid conditions. After irradiation, a dark-red color, reflections due to Cu metal in the X-ray diffraction pattern, and peaks due to Cu 2p1/2 and 2p3/2 in the X-ray photoelectron spectrum indicated the precipitation of Cu metal in the product. In addition, an increase in the Brunauer–Emmett–Teller specific surface area from 36 and 45 m2/g for the silica–surfactant and TiO2, respectively, to 591 m2/g for the product, and a decrease in the intensity of the C-H stretching band in the Fourier–transform infra-red spectra implied the removal of surfactant during the reaction. These characteristics were never observed when TiO2 was used solely. Therefore, this study indicated that the photoreduction of Cu2+ ions to Cu metal by TiO2 was facilitated under the sulfuric acid medium, where the surfactants extracted from silica–surfactant hybrids by protons in the acidic condition were successfully photo-oxidized by TiO2. Thus, this study presents a new application of the conversion of a silica–surfactant hybrid into mesoporous silicas. 相似文献
83.
Murakami T Nobukawa Y Tabata M Ueda M Yasuda Y Suzuki H Shigemi K 《Masui. The Japanese journal of anesthesiology》2007,56(10):1214-1216
We report two cases of atraumatic iliopsoas hematoma. First patient was a 76-year-old man admitted to our hospital from appetite loss. Blood transfusion did not improve his anemia. Five days after admission, suddenly he went into shock. CT scan revealed ileopsoas hematoma. He died from hemorrhagic shock in spite of conservative therapy. Second patient was a 70-year-old man admitted because of acute heart failure. Continuous hemodiafiltration was required to relieve anuria. The next day, he developed left leg and hip pain. CT scan revealed ileopsoas hematoma and he received CT guided aspiration drainage for decompression, but almost 7 days were needed to achieve successful pain control. In a case of iliopsoas hematoma, early diagnosis and adequate choise of therapy are necessary to improve prognosis of patients. 相似文献
84.
85.
86.
87.
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. 总被引:1,自引:0,他引:1
Shyamal Chandra Bir Masatoshi Fujita Akira Marui Keiichi Hirose Yoshio Arai Hisashi Sakaguchi Yuhong Huang Jiro Esaki Tadashi Ikeda Yasuhiko Tabata Masashi Komeda 《Circulation journal》2008,72(4):633-640
BACKGROUND: The combined treatment of sustained-release basic fibroblast growth factor (Sr-bFGF) and a 5-hydroxytryptamine(2A) blocker, sarpogrelate, was evaluated to see whether it reversed the impaired collateral circulation in diabetic (DM) mouse hindlimb ischemia. METHOD AND RESULTS: Diabetic and normal mice with ischemic hindlimb were randomly assigned to 1 of 5 experimental groups (no treatment, sarpogrelate 50 mg . kg(-1) . day(-1), 20 microg or 50 microg Sr-bFGF and a combined treatment of 20 microg Sr-bFGF and sarpogrelate), and treated for 4 weeks. Tissue blood perfusion (TBP), vascular density (angiogenesis) and the number of mature vessels (arteriogenesis) were checked by the use of standard methods. Although angiogenesis was comparable (161+/-14 vs 154+/-12 vessels/mm(2)), the laser Doppler perfusion image index (LDPII) (0.43+/-0.11 (SD) vs 0.63+/-0.08, p<0.05) and arteriogenesis (8+/-3 vs 12+/-4 vessels/mm(2), p<0.05) were significantly lower in DM mice than those in normal mice. The dose of Sr-bFGF for the sufficient number of mature vessels (>or=45 vessels/mm(2)) and LDPII (>or=0.9) was 20 microg for the normal mice, and 50 microg for the DM mice, which was reduced with the aid of sarpogrelate. Conclusions A combined therapy of Sr-bFGF and sarpogrelate is effective for neovascularization to reverse the impaired arteriogenesis and TBP in DM mice. 相似文献
88.
Altered relationship between body fat and plasma adiponectin in end-stage renal disease 总被引:2,自引:0,他引:2
Shoji T Shinohara K Hatsuda S Kimoto E Fukumoto S Emoto M Tahara H Koyama H Ishimura E Miki T Tabata T Nishizawa Y 《Metabolism: clinical and experimental》2005,54(3):330-334
Patients with end-stage renal disease (ESRD) show an inverse association between body mass index and risk of death from cardiovascular disease. Paradoxical epidemiology may suggest some beneficial effects of body fat in ESRD. Because an antiatherogenic adipocytokine adiponectin is increased in uremic plasma, we tested a hypothesis that, in ESRD, plasma adipocytokine profile may be less atherogenic or that the relationship between body fat and adipocytokines may be altered. The subjects were 103 patients with ESRD undergoing hemodialysis and 166 healthy subjects comparable in age and sex. We measured body fat mass by dual-energy x-ray absorptiometry and plasma levels of adiponectin and leptin by enzyme-linked immunosorbent assay. The ESRD group showed a significant increase in plasma adiponectin, leptin, and adiponectin/leptin ratio than the healthy subjects. Although sex and fat mass were significant factors correlating with plasma adiponectin level in the healthy group, none of these were significantly associated with plasma adiponectin in the patients with ESRD. In contrast, leptin showed significant relationships with sex and fat mass regardless of the presence of ESRD. Plasma adiponectin correlated negatively with plasma triglycerides and positively with high-density lipoprotein cholesterol in both healthy and ESRD groups, suggesting that uremic adiponectin retains its actions in favor of its antiatherogenicity. Thus, plasma adipocytokine profile was altered in ESRD, and the effects of body fat and sex on adiponectin were less significant in the patients with ESRD. 相似文献
89.
Mori M Imagawa T Katakura S Miyamae T Okuyama K Ito S Nakamura T Kimura H Yokota S 《Modern rheumatology / the Japan Rheumatism Association》2004,14(1):43-47
Kawasaki disease (KD) causes coronary artery lesions (CALs) in 500 Japanese children each year. Intravenous gamma-globulin (IVGG) decreases the incidence of these lesions from 25% to 8% of the total KD cases. We examined whether plasma exchange is a safe and effective prophylaxis against CALs in children with KD intractable to IVGG therapy. Eighty-nine children with KD at high risk of CALs were selected on the basis of increases in fractional changes in inflammatory markers such as white blood cell count, neutrophil count, and C-reactive protein between the baseline and 1–2 days after IVGG treatment. Of 105 children who received a second course of IVGG therapy because the initial course was ineffective, plasma exchange (PE) was performed in 46 children who had not responded to the second IVGG treatment. The outcome was compared with the results when a third course of IVGG therapy was given to the other 59 children. No complications occurred with the plasma exchange therapy. CALs developed in only 8 of the 46 children (17.3%) who underwent plasma exchange, but they occurred in 24 of the 59 (40.7%) who had received a third course of IVGG therapy (P 0.0012). We concluded that PE was a safe, effective prophylactic measure against CALs in children with KD intractable to IVGG therapy. PE should be performed at an early stage, as soon as fractional increases in inflammatory markers are found after IVGG therapy. 相似文献
90.
Yagi S Aihara K Ikeda Y Sumitomo Y Yoshida S Ise T Iwase T Ishikawa K Azuma H Akaike M Matsumoto T 《Circulation research》2008,102(1):68-76
Angiotensin II (Ang II) plays a pivotal role in cardiovascular remodeling leading to hypertension, myocardial infarction, and stroke. Pitavastatin, an HMG-CoA reductase inihibitor, is known to have pleiotropic actions against the development of cardiovascular remodeling. The objectives of this study were to clarify the beneficial effects as well as the mechanism of action of pitavastatin against Ang II-induced organ damage. C57BL6/J mice at 10 weeks of age were infused with Ang II for 2 weeks and were simultaneously administered pitavastatin or a vehicle. Pitavastatin treatment improved Ang II-induced left ventricular hypertrophy and diastolic dysfunction and attenuated enhancement of cardiac fibrosis, cardiomyocyte hypertrophy, coronary perivascular fibrosis, and medial thickening. Ang II-induced oxidative stress, cardiac TGFbeta-1 expression, and Smad 2/3 phosphorylation were all attenuated by pitavastatin treatment. Pitavastatin also reduced Ang II-induced cardiac remodeling and diastolic dysfunction in eNOS-/- mice as in wild-type mice. In eNOS-/- mice, the Ang II-induced cardiac oxidative stress and TGF-beta-Smad 2/3 signaling pathway were enhanced, and pitavastatin treatment attenuated the enhanced oxidative stress and the signaling pathway. Moreover, pitavastatin treatment reduced the high mortality rate and improved renal insufficiency in Ang II-treated eNOS-/- mice, with suppression of glomerular oxidative stress and TGF-beta-Smad 2/3 signaling pathway. In conclusion, pitavastatin exerts eNOS-independent protective actions against Ang II-induced cardiovascular remodeling and renal insufficiency through inhibition of the TGF-beta-Smad 2/3 signaling pathway by suppression of oxidative stress. 相似文献